z-logo
open-access-imgOpen Access
AB086. HLA-B*1502 and HLA-B*5801 genotyping for the prevention of severe cutaneous adverse drug reactions in a Children’s Hospital
Author(s) -
Leng Kee Ching,
W T Low,
Yuen Ming Tan
Publication year - 2017
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2017.s086
Subject(s) - toxic epidermal necrolysis , medicine , allopurinol , scars , carbamazepine , dermatology , adverse effect , genotyping , gout , epilepsy , adverse drug reaction , drug , genotype , pharmacology , surgery , genetics , biology , psychiatry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom